ALEC insider files Form 144 to sell 14,000 restricted shares via Morgan Stanley
Rhea-AI Filing Summary
Alector, Inc. (ALEC) filed a Form 144 reporting a proposed sale of 14,000 shares of common stock, scheduled to be sold through Morgan Stanley Smith Barney LLC on 08/26/2025 on Nasdaq for an aggregate market value of $32,996.60. The filer reports total shares outstanding of 101,212,329. The shares were acquired as restricted stock from the issuer on 06/11/2025, with payment dated the same day. No securities sales by the filer in the past three months are reported. The filer affirms they are not aware of undisclosed material adverse information and includes the standard signature and certification language required by Rule 144.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small insider sale of restricted shares; immaterial to capitalization but notable as a recently acquired restricted stock disposition.
The filing documents a relatively small proposed sale representing approximately 0.0138% of the reported outstanding shares (14,000 of 101,212,329). The transaction involves restricted stock granted by the issuer on 06/11/2025 and planned brokerage execution through Morgan Stanley on 08/26/2025. Given the low absolute value (<$33k) versus total shares outstanding, this is unlikely to move market valuations or indicate a broad insider sell-down, though investors may note timing and the fact the securities were recently issued.
TL;DR: Compliance filing appears routine and appropriately discloses a proposed sale under Rule 144.
The Form 144 contains required disclosures: broker details, acquisition as restricted stock from the issuer, and the filer’s representation about material nonpublic information. It reports no sales in the prior three months, which supports that this is an isolated, authorized disposition. From a governance perspective, documentation is complete for a Rule 144 notice and does not by itself signal governance or disclosure concerns.